PharmaEssentia Completes Patient Enrollment for Phase 2b EXCEED-ET Trial in Essential Thrombocythemia and Phase 3b ECLIPSE-PV Trial in Polycythemia Vera

“Myeloproliferative neoplasms, including ET and PV, are chronic blood diseases [...]